期刊文献+

经尿道钬激光切除联合吡柔比星灌注治疗浅表性膀胱癌临床分析 被引量:6

Clinical analysis of treating superficial bladder carcinoma using transurethral holmium laser resection combine with instant intravesical Pirarubicin instillation
暂未订购
导出
摘要 目的探讨经尿道钬激光切除联合吡柔比星灌注治疗浅表性膀胱癌的疗效。方法 2008年2月~2011年6月,我科收治71例浅表性膀胱癌患者,随机分为对照组和治疗组两组。对照组35例患者采用经尿道膀胱癌电切术治疗;治疗组36例患者采用经尿道钬激光膀胱癌切除术治疗,术后即刻予膀胱内无菌蒸馏水60 mL加吡柔比星30 mg灌注1次。两组术后拔除导尿管时予无菌蒸馏水60 mL加吡柔比星30 mg灌注1次,以后每周1次,连续灌注8周后改为每个月1次,持续灌注至术后1年。结果对照组平均手术时间为32.5 min,1例发生术中膀胱穿孔,术后留置导尿管时间平均6 d,9例患者术后复发;治疗组平均手术时间为33.4 min,术中未出现膀胱穿孔,术后留置导尿管时间平均3 d,2例患者术后复发。两组之间平均手术时间、膀胱穿孔例数无统计学差异(P>0.05),治疗组术后导尿管留置时间、肿瘤复发例数均低于对照组(P<0.05)。结论经尿道钬激光切除联合吡柔比星灌注治疗浅表性膀胱癌的效果优于单纯电切术,术后复发率低、患者恢复快,临床效果好,值得临床推广应用。 Objective To investigate the application and clinical result of treating superficial bladder carcinoma using transurethral holmium laser resection combine with instant intravesical pirarubicin instillation. Methods Between February 2008 to June 2011,71 patients with superficial bladder carcinoma were treated in our department. They were divided into two groups according to the random digits table. The 35 patients in the control group were treated with transurethral electroresection. The 36 patients in the observation group were treated with transurethral holmium laser resection combine with instant intravesical pirarubicin instillation. The intravesical pirarubicin instillation was immediately after operation with 60mL distilled water combine with 30 mg pirarubicin. The above intravesical pirarubicin instillation was done again when urethral catheter was extracted in the two groups. The instillation was performed once a week until eight weeks later. The instillation was performed once a month in the later one year. Results In the control group, the mean operation time was 32.5 min;there was one patient had vesical perforation during operation ;the mean time of indwelling urethral catheter was 6d;and there were nine patients with recurrence.In the observation group,the mean operation time was 33.4 min;there was no patient had vesical perforation during operation; the mean time of indwelling urethral catheter was 3 d;and two were three patients with recurrence. No significant deviation was observed in the two groups in the operation time and vesical perforations (P 〉 0.05 ). Significant deviation of the time of indwelling urethral catheter and the recurrence was observed in the two groups(P 〈 0.05). Conclusion Transurethral holmium laser resection combine with instant intravesical pirarubicin instillation is an effective method compare with transurethral electroresection in treating superficial bladder carcinoma. It has low recurrence rate with good clinical result.
作者 贾洪波 钟伟
出处 《中国现代医生》 2012年第30期157-158,160,共3页 China Modern Doctor
关键词 浅表性膀胱癌 激光手术 钬激光 吡柔比星 局部灌注 Superficial bladder carcinoma Laser resection Holmium laser Pirarubicin Local instillation
  • 相关文献

参考文献8

二级参考文献31

  • 1陈南辉,张圣杰,李晓飞,张伟.腔镜下钬激光内切开加定期尿道扩张治疗男性尿道狭窄及闭锁[J].岭南现代临床外科,2010,10(3):216-217. 被引量:6
  • 2田溪泉,邢念增,王勇,李建兴.早期吡柔比星膀胱内灌注预防膀胱癌术后复发[J].临床泌尿外科杂志,2006,21(1):4-6. 被引量:35
  • 3张力,鲍业忠.膀胱部分切除术和TURBt治疗膀胱肿瘤的对照及应用[J].现代医药卫生,2006,22(23):3412-3413. 被引量:3
  • 4荻原雅彦 相川键 等.不同药物膀胱灌注预防浅表性膀胱癌复发的研究[J].临床泌尿,1994,8:603-608.
  • 5Palmieri F,Brunocilla E,Bertaccini A,et al.Prognostic value of lymphovascular invasion in bladder cancer in patients treated with radical cystectomy.Anticancer Res,2010,30(7):2973-2976.
  • 6TAKAHASHI T,KUSHIRO A, NOMOTOK, et al. Antitumor elects of the intravesical instillation of heat killed ceils of the Laetobacillus easei strain Shirota on the murine orthotopic bladder tumor MBT-2[J].J Urol,2001,166(12):2506-2511.
  • 7KURODAK, ISHII N, FUKASAWA K, et al. Shortterm intravesical instillation of pirarubicin (THP) in prophylactic treatment after transurethral resection of superficial bladder tumor[J].HinyokikaKiyo, 1998,44(8):547-552.
  • 8LMM KL. Prophylaxis for recurrent transitional cell carcinoma [J].Urology, 19 91,37 (Suppl 5) : 21.
  • 9ALIELDEN B. NABEEH A, ELBAZ M, et al. Singledose versus multiple instillation of epirubicin as prophylaxis for recurrence after transurethral of pTa and pT1 transitional cell bladder tumour : a prospective . randomized controlled study[J]. BrJ Uro1,1997,79(5) ,730-735.
  • 10IBORRA I, RICO'S JV, MONRO'S JL, et al. Resultados de un estudio de quimioprofilaxis intravesicah prospectivo, doble aleatorio, entre dos drogas: La Adriamicina y elmitomicin; y dos rnodos de iniciar las instilaciones: precoz y tard'o. Efecto sobre larecidivay la progresio' n[J].Arch Esp Urol, 1992,45 : 1001-1007.

共引文献63

同被引文献39

引证文献6

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部